Found 16 matching trials
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer PHASE2 Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Show More Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Learn More & Join Trial
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 PHASE2 To evaluate the outcome of a prednisolone and low dose methotrexate based p...
Show More Status
Active Not Recruiting
Location
Prince of Wales Hospital
Learn More & Join Trial
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia PHASE3 ALLTogether collects the experience of previously successful treatment of i...
Show More Location
L'hôpital Universitaire des enfants Reine Fabiola (Huderf)
Learn More & Join Trial
Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD in Classic Hodgkin Lymphoma PHASE2 This study enrolls newly diagnosed unfavorable stage II /stage III-IV class...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
ABT-751 With Chemotherapy for Relapsed Pediatric ALL PHASE1 This is a phase I/II study of an investigational drug called ABT-751, produ...
Show More Location
Childrens Hospital Los Angeles
Learn More & Join Trial
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors PHASE2 This protocol will study treatment for Ewing sarcoma family of tumors (ESFT...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma PHASE2 The Purpose of this trial is:
* to determine complete response rate (CRR) ...
Show More Location
1st Dept. of Medicine, Cologne University Hospital
Learn More & Join Trial
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma PHASE1 RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE) PHASE2 Soft tissue sarcomas (STSs) are rare cancers with a 5-year survival rate of...
Show More Location
Kantonsspital Aarau
Learn More & Join Trial
GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) PHASE2 St Bartholomew's hospital completed a study using the regimen GAMEC (PEG-fi...
Show More Location
Barts and the London NHS Trust
Learn More & Join Trial